JRSS · JRSIS HEALTH CARE Corp
Market Cap
$1.52M
Shares
84.60M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$3.46M
+101.4%
FY2023
Net Income
-$80.91K
+85.9%
FY2023
Gross Margin
13.95%
+12.4pp
FY2023
Operating Margin
-5.45%
+34.4pp
FY2023
Diluted EPS
-$0.00
+88.9%
FY2023
Operating Cash Flow
$516.72K
+129.3%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.47M | $3.46M | $1.72M | $44.39M | $35.71M | $31.46M | $28.4M | $24.15M | $18.12M | $11.87M | $5.98M | $4.35M | |
| — | — | $1.34M | — | — | — | — | — | — | — | — | — | |
| $3.03M | $2.98M | $1.69M | — | — | — | — | $7.06M | $4.88M | $3.33M | $1.74M | $1.25M | |
| $442.16K | $483.05K | $26.21K | — | — | — | — | — | — | — | — | — | |
| — | 13.95% | 1.52% | — | — | — | — | — | — | — | — | — | |
| $133.12K | $189.27K | $283.04K | — | — | — | — | — | — | — | — | — | |
| $436.26K | $146.33K | $144.65K | — | — | — | — | — | — | — | — | — | |
| $548.45K | $336.05K | $283.29K | — | — | — | — | — | — | — | — | — | |
| $37.05K | $37.31K | $39.26K | — | — | — | — | — | — | — | — | — | |
| $71.56K | $53.82K | $5796 | — | $2.7M | $2.21M | — | — | — | — | — | — | |
| $1.12M | $671.65K | $710.99K | — | — | — | — | — | — | — | — | — | |
| -$675.66K | -$188.6K | -$684.78K | -$103.8K | $5.59M | $4.67M | $5.99M | $6.66M | $5.02M | $2.63M | $917.96K | $1.32M | |
| — | -5.45% | -39.83% | -0.23% | 15.67% | 14.83% | 21.1% | 27.57% | 27.72% | 22.15% | 15.35% | 30.29% | |
| -$604.1K | -$134.78K | -$678.98K | — | $8.29M | $6.88M | — | — | — | — | — | — | |
| — | $56.44K | $64.71K | $1.38M | $1.14M | $1.11M | $1.13M | $1.32M | $1.38M | $1.24M | $1.01M | $12.77K | |
| $106.64K | $102.99K | $11.52K | $266.96K | -$396.5K | -$2.74M | -$379.49K | -$16.23K | $934 | $9321 | — | — | |
| -$569.02K | -$85.61K | -$673.26K | -$103.8K | $5.2M | $1.93M | $5.61M | $6.64M | $5.02M | $2.64M | $943.26K | $1.32M | |
| — | $8975 | — | $1.18M | $1.37M | $657.7K | $2.77M | $2528 | $4059 | $2604 | $2157 | $1984 | |
| -$503.66K | -$80.91K | -$575.84K | $3.19M | $3.83M | $888.06K | $1.99M | $4.65M | $3.47M | $1.79M | $611.49K | $399.98K | |
| — | -2.34% | -33.5% | 7.18% | 10.72% | 2.82% | 7.02% | 19.24% | 19.16% | 15.08% | 10.23% | 9.19% | |
| -$82.87K | -$13.68K | -$97.42K | $956.68K | $1.15M | $380.6K | $854.13K | $1.99M | $1.55M | $845.47K | $329.61K | $922.72K | |
| — | -$80.91K | -$575.84K | $2.23M | $2.68M | $888.06K | $1.99M | $4.65M | $3.47M | $1.79M | — | — | |
| -$492.04K | -$79.03K | -$530.35K | $2.89M | $3.8M | $634.3K | $1.1M | $5.34M | $2.95M | $1.52M | $601.68K | $423.84K | |
| USD/shares | -$0.01 | -$0.00 | -$0.01 | $0.17 | $1.48 | $0.53 | $1.33 | — | — | — | $0.45 | $2.90 |
| USD/shares | -$0.01 | -$0.00 | -$0.01 | $0.17 | $1.47 | $0.53 | $1.33 | — | — | — | $0.45 | $2.90 |
| shares | — | 77.25M | 61.33M | 18.45M | 1.81M | 1.68M | 1.49M | 1.43M | 1.39M | 1.39M | 1.35M | 138.08K |
| shares | — | 77.25M | 61.33M | 18.66M | 1.83M | 1.68M | 1.49M | 1.43M | 1.39M | 1.39M | 1.35M | 138.08K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 35 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1597892